Skip to main content
. 2007 Sep 26;81(24):13587–13597. doi: 10.1128/JVI.00547-07

TABLE 2.

Plasmids used in this study

Plasmid Description
Plasmid Fa PCR-XL-Topo vector containing a 6.9-kb DNA fragment of MHV cDNA (bp 15755-22739 on the MHV-A59 genome)
pWtNsp15-PG pGEM-T (Promega, Madison, WI) containing a PCR product corresponding to a 3.4-kb BamHI-HpaI fragment in plasmid F of MHV cDNA
p1F-PG pWtNsp15-PG containing an H262A mutation in mNsp15
pHK1Fb Plasmid F containing the mNsp15 H262A mutation
p2F-PG pWtNsp15-PG containing a G275A mutation in mNsp15
pHK2F Plasmid F containing the mNsp15 G275A mutation
p3F-PG pWtNsp15-PG containing an H277A mutation in mNsp15
pHK3F Plasmid F containing the mNsp15 H277A mutation
p4F-PG pWtNsp15-PG containing a D324A mutation in mNsp15
pHK4F Plasmid F containing the mNsp15 D324A mutation
pcD-mNsp15 pcDNA1 (Invitrogen, Carlsbad, CA) containing mNsp15 coding sequence
pcD-sNsp15 pcDNA1 containing sNsp15 coding sequence
pcD-GFP-sNsp15 pcDNA1 containing GFP conjugated to the N terminus of the mNsp15 coding sequence
a

One of seven plasmids used in the MHV-A59 reverse-genetic system (30).

b

The BamHI-HpaI fragment containing the H262A mutation in p1F-PG was excised and religated into BamHI-HpaI-digested plasmid F to construct pHK1F. Plasmids pHK2F, pHK3F, and pHK4F were constructed using p2F-PG, p3F-PG, and p4F-PG, respectively, with the same protocol as that for the construction of pHK1F.